Skip to main content
rounds.

Evidence digest

Cornea & External Disease: the evidence, summarized every weekday

Peer-reviewed papers in cornea & external disease, summarized and ranked by evidence level. Top studies from PubMed and ClinicalTrials.gov. Updated every weekday at 06:00 CET. Built by physicians, for physicians.

Subscribe · €49 / year →See the methodology →

What rounds. covers in cornea & external disease

  • Keratoconus & Cross-linking
  • DMEK/DSAEK
  • Infectious keratitis
  • Dry eye disease
  • Ocular surface tumors
  • Corneal dystrophies

Landmark papers · cornea & external disease

Hand-picked by the editorial team. These are the studies that shaped current practice in cornea & external disease.

  1. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).

    Archives of ophthalmology · Srinivasan M. et al. · Sunday, January 1, 2012

  2. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.

    JAMA ophthalmology · Prajna N. et al. · Tuesday, January 1, 2013

  3. n‐3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease

    The New England Journal of Medicine · Asbell P. et al. · Monday, January 1, 2018

How papers reach the cornea & external disease brief

  1. Source. Every paper is fetched directly from PubMed and ClinicalTrials.gov. No paywalled aggregators. No editorial press releases.
  2. Grading. Each paper is assigned an evidence level from L1 (RCT or meta-analysis) to L5 (editorial). Bias risk is flagged separately. Both labels are visible on every card.
  3. Summarization. A 5-gate validator stack checks every summary for source faithfulness, numeric accuracy, drug-safety language, unsupported claims, and clinical-decision overreach. Anything that fails a gate is blocked, not silently weakened.
  4. Delivery. Ten papers. Twelve minutes. Every weekday at 06:00 CET. Subscribers can rate any paper as off-topic and it drops out of their feed.

The full pipeline, validators, and the founder's editorial overrides are documented on the methodology page.

Frequently asked

How do I keep up with new cornea & external disease research?
rounds. reads the new cornea & external disease literature from PubMed and ClinicalTrials.gov every weekday, grades each paper on the CEBM evidence hierarchy, and delivers the few that change practice as a twelve-minute morning brief. Every summary is checked claim by claim against the source paper.
What are the landmark cornea & external disease trials?
The studies that shaped current cornea & external disease practice are listed above under “Landmark papers”, each linked to a structured summary with its evidence level, effect size, and bias signals.
Is rounds. free?
The morning scan is free. Pro (€49 / year) unlocks the full ten-paper daily brief, the full read on every paper, and the 06:00 CET email, Monday to Friday.

Other subspecialties